Search

everythinglearnresearchcommunity

for

Search:↓

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Hair loss may increase heart disease risk.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Raspberry ketone lacks sufficient human research to support health benefit claims and requires more rigorous studies to confirm its safety and effectiveness.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Birth control pills can help reduce mild to moderate acne in women.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Possible link between androgens and COVID-19 severity; more research needed.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

The emulgel with Saw Palmetto and Sophora Japonica shows promise for treating hair loss.

Melatonin-loaded microemulsion could be a promising treatment for hair loss.